Literatur
(Evidenzstärke gemäß Ärztliche Zentralstelle Qualitätssicherung in Klammern)
-
1
EASL International Consensus Conference on Hepatitis C .
Consensus statement.
J Hepatol.
1999;
30
956-961 (IV)
-
2
Hopf U, Niederau C, Kleber G. et al .
Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Virushepatitis C. Konsensus der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.
Z Gastroenterol.
1997;
35
971-986 (IV)
-
3
National Institutes of Health consensus development conference statement .
Management of hepatitis C: 2002.
Hepatology.
2002;
36
S3-S20 (IV)
-
4
Alvarez F, Berg P A, Bianchi F B. et al .
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
J Hepatol.
1999;
31
929-938 (IV)
-
5
Dienstag J L.
The role of liver biopsy in chronic hepatitis C.
Hepatology.
2002;
36
S152-S160 (IV)
-
6
Marcellin P, Asselah T, Boyer N.
Fibrosis and disease progression in hepatitis C.
Hepatology.
2002;
36
S47-S56 (IV)
-
7
Pradat P, Poynard T, Alberti A. et al .
Predictive value of ALT levels for histologic findings in chronic Hepatitis C: a European collaborative study.
Hepatology.
2002;
36
973-977 (III)
-
8
Gebo K A, Herlong H F, Torbenson M S.
Role of liver biopsy in management of chronic hepatitis C: a systematic review.
Hepatology.
2002;
36
S161-S172 (III)
-
9
Crawford A R, Lin X Z, Crawford J M.
The normal adult human liver biopsy: A quantitative reference standard.
Hepatology.
1998;
28
323-331 (IIb)
-
10
Piccinino F, Sagnelli E, Pasquale G. et al .
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies.
J Hepatol.
1986;
2
165-173 (III)
-
11
Miniuk G Y, Sutherland L R, Wiseman D A. et al .
Prospective study of the incidence of ultrasound-detected intrahepatic and subcapsular hematomas in patients randomized to 6 or 24 hours of bedrest after percutaneous liver biopsy.
Gastroenterology.
1987;
92
290-293 (Ib)
-
12
Hederström E, Forsberg L, Florén C H. et al .
Liver biopsy complications monitored by ultrasound.
J Hepatol.
1989;
8
94-98 (IV)
-
13
McGill D B, Rakela J, Zinsmeister A R. et al .
A 21-year experience with major hemorrhage after percutaneous liver biopsy.
Gastroenterology.
1990;
99
1396-1400 (IIa)
-
14
Conn H O.
Liver biopsy: increased risks in patients with cancer.
Hepatology.
1991;
14
206-209 (III)
-
15
Gordon S C, Veneri R J, McFadden R F. et al .
Major hemorrhage after percutaneous liver biopsy in patients with AIDS.
Gastroenterology.
1991;
100
1787 (IV)
-
16
Özdogan M, Özgür O, Boyacioglu S. et al .
Percutaneous liver biopsy complications in patients with chronic renal failure.
Nephron.
1996;
74
442-444 (III)
-
17
Terjung B, Lemnitzer I, Dumoulin F L. et al .
Bleeding complications after percutaneous liver biopsy: an analysis of risk factors.
Digestion.
2003;
67
138-145 (III)
-
18
Guidelines on the use of liver biopsy in clinical practice.
Gut.
1999;
45 (Suppl. IV)
1-11 (IV)
-
19
Desmet V J, Gerber M, Hoofnagle J H. et al .
Classification of chronic hepatitis: diagnosis, grading and staging.
Hepatology.
1994;
19
1513-1520 (IV)
-
20
Batts K P, Ludwig J.
Chronic hepatitis - an update on terminology and reporting.
Am J Surg Pathol.
1995;
19
1409-1417 (IV)
-
21
Ishak K G, Baptista A, Bianchi L. et al .
Histological grading and staging of chronic hepatitis.
J Hepatol.
1995;
22
696-699 (IV)
-
22
Bedossa P, Poynard T for the METAVIR Cooperative Study Group .
An algorithm for the grading of activity in chronic hepatitis C.
Hepatology.
1996;
24
289-293 (III)
-
23
De Groote J, Desmet V, Gedigk P. et al .
A classification of chronic hepatitis.
Lancet.
1968;
ii
626-628
-
24
Goldin R D, Goldin J G, Burt A D. et al .
Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.
J Hepatol.
1996;
25
649-654 (III)
-
25
Knodell R G, Ishak K G, Black W C. et al .
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.
Hepatology.
1981;
1
431-435
-
26
Scheuer P J.
Classification of chronic viral hepatitis: a need for reassessment.
J Hepatol.
1991;
13
372-374 (IV)
-
27
The METAVIR Cooperative Group .
Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C.
Hepatology.
1994;
20
15-20 (III)
-
28
Chevallier M, Guerret S, Chossegros P. et al .
A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies.
Hepatology.
1994;
20
349-355 (IIb)
-
29
Dries V, von Both I, Müller M. et al .
Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum.
Hepatology.
1999;
29
223-229 (IIb)
Prof. Dr. P. Schirmacher
Institut für Pathologie, Universität zu Köln
Joseph-Stelzmann-Str. 9
50931 Köln
eMail: Peter.schirmacher@uni-koeln.de
